JPRN-UMIN000036853尚未招募未知
Examination about the effect of the efficacy and safety by the presence or absence of the combination of romosozumab and active vitamin D3 preparation - Examination about the effect of the efficacy and safety by the presence or absence of the combination of romosozumab and active vitamin D3 preparation
Shinshu University School of Medicine Dept. of Orthopaedic Surgery0 个研究点目标入组 90 人开始时间: 2019年5月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1:Patients who are allergic to romosozumab or eldecalcidol or alfacalcidol 2:Pregnant or breast-feeding patients 3:Hypocalcemia 4:Patients with severe renal function (eGFR 30 ml / min / 1.73 m2) or patients undergoing dialysis 5:Patients at risk of hypercalcemia (patients with renal dysfunction, patients with malignancy, patients with primary hyperparathyroidism) 6:Patients with severe liver dysfunction 7:Patients with urolithiasis and patients with a history of their history 8:Others, patients judged by the research director as inappropriate
研究者
相似试验
已完成
不适用
Evaluation and comparison of efficacy and adverse drug reactions for single or two divided caffeine dosing to treat apnea of prematurity in preterm neonatesApnea of prematurity.Other preterm infantsIRCT201510172342N4Vice chancellor for Research, Mazandaran University of Medical Sciences40
招募中
不适用
Comparison of the efficay and side effects of nebulized oral pulmicort and inhaler budesonide in patients with eosinophilic esophagitisEosinophilic esophagitisIRCT20191211045703N1Iran University of Medical Sciences60
已完成
不适用
Study of the effectiveness and safety of LigaSure™ in hysterectomyTransvaginal hysterectomyUrological and Genital DiseasesISRCTN13646289Covidien Private Limited72
招募中
4 期
EFfect of C.Palmitole(Palmtoylethanolamide,Genistein,Diadzein) in treating Nerves affected by DiabetesCTRI/2024/02/063245Government Kilpauk Medical College
尚未招募
4 期
A diabetic study to find the safety and efficacy of newer drug Imeglimin.CTRI/2023/06/053822Dr Shaki Sam